debate: immunomodulators and anti-tnfs must be stopped when an infection occurs
Published 10 years ago • 132 plays • Length 12:12Download video MP4
Download video MP3
Similar videos
-
12:53
biologic therapy should never be stopped, or should it?
-
11:32
debate: ibd patient on biologic or immunomodulator who develops a malignancy - must stop these meds
-
31:51
case discussion: management of infections in ibd patients on immunomodulators and/or biologics
-
21:09
infections due to immunomodulators and/or biologics: identification, prevention and treatment
-
16:10
when should we stop anti-tnf therapy and how do we then treat the patient?
-
19:03
debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
-
14:13
what do we do when the patient loses their response to an anti-tnf?
-
24:47
diagnosis and management of infections in ibd patients on immunomodulators and biologics
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
21:18
how can we prevent and manage the common side effects of immunomodulators and biologics?
-
14:56
debate: is therapeutic drug monitoring necessary with anti-tnf therapy? - yes
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators
-
16:37
debate: is therapeutic drug monitoring necessary with anti-tnf therapy? - no
-
26:25
understanding non-response and loss of response in ibd: which is it and when do we change classes?
-
18:01
debate: combination or monotherapy with anti-tnf? - combination
-
18:22
other major side effects due to immunomodulators and/or biologics in our ibd patients
-
11:37
debate: is combination therapy necessary if you use anti-tnf? - yes
-
0:12
an easier way to remember gluconeogenesis enzymes #medstudent #biology #biochemistry
-
17:18
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - no biologics